Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-020878
Filing Date
2022-08-01
Accepted
2022-08-01 16:10:12
Documents
1
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4363
  Complete submission text file 0001493152-22-020878.txt   5798
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Issuer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address MOSHAV AZRIEL 108 LEV HASHARON L3 4582500
Business Address
LEVIN GADI (Reporting) CIK: 0001740586 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40101 | Film No.: 221124820